Fermenta Biotech informs about successful closure of inspection

06 Jul 2024 Evaluate

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Fermenta Biotech has informed that US FDA has issued an Establishment Inspection Report (EIR) for the Company’s manufacturing facility situated at Dahej, Gujarat, India with no observations as to any significant objectionable conditions, and the inspection has been successfully ‘closed’ by the US FDA.

The above information is a part of company’s filings submitted to BSE.

Fermenta Biotech Share Price

324.00 -2.00 (-0.61%)
22-Jan-2026 14:44 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1628.80
Dr. Reddys Lab 1217.85
Cipla 1370.00
Zydus Lifesciences 884.55
Lupin 2161.20
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×